Necrotising enterocolitis in a newborn infant treated with octreotide for chylous effusion: is octreotide safe?

Octreotide is a somatostatin analogue used for treating congenital chylothorax and congenital hyperinsulinism in infants. By increasing splanchnic arteriolar resistance and decreasing gastrointestinal blood flow, octreotide indirectly reduces lymphatic flow in chylous effusions. Splanchnic ischaemia...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMJ Case Rep
Autori principali: Chandran, Suresh, Agarwal, Arpan, Llanora, Genevieve Villablanca, Chua, Mei Chien
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group 2020
Soggetti:
Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7021135/
https://ncbi.nlm.nih.gov/pubmed/32051156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2019-232062
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi